Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
10 min read
Smith-Magenis syndrome Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 Smith-Magenis syndrome strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP evidence.
Latest Hotspot
10 min read
Rubinstein-Taybi syndrome Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 Rubinstein-Taybi syndrome strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP evidence.
Latest Hotspot
10 min read
Coffin-Siris syndrome Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 Coffin-Siris syndrome strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP evidence.
Latest Hotspot
10 min read
Cornelia de Lange syndrome Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 Cornelia de Lange syndrome strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP evidence.
Latest Hotspot
10 min read
Kabuki syndrome Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
Explore the 2026 Kabuki syndrome indication strategy: epidemiology, unmet need, target biology, clinical competition and deal signals using PatSnap MCP evidence.
Latest Hotspot
10 min read
CHARGE syndrome Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
Explore the 2026 CHARGE syndrome indication strategy: epidemiology, unmet need, target biology, clinical competition and deal signals using PatSnap MCP evidence.
Latest Hotspot
10 min read
22q11.2 deletion syndrome Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 22q11.2 deletion syndrome strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP evidence.
Latest Hotspot
10 min read
Pierre Robin sequence Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 Pierre Robin sequence strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP evidence.
Latest Hotspot
10 min read
Treacher Collins syndrome Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 Treacher Collins syndrome strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP evidence.
Latest Hotspot
10 min read
Empty sella-associated CSF rhinorrhea Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 Empty sella-associated CSF rhinorrhea strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap.
Latest Hotspot
10 min read
Chronic smell loss Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
Explore the 2026 Chronic smell loss indication strategy: epidemiology, unmet need, target biology, clinical competition and deal signals using PatSnap MCP evidence.
Latest Hotspot
10 min read
Congenital anosmia Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
Explore the 2026 Congenital anosmia indication strategy: epidemiology, unmet need, target biology, clinical competition and deal signals using PatSnap MCP evidence.